Human islet allotransplantation with Basiliximab in type I diabetic patients with end-stage renal failure
Published inTransplantation proceedings, vol. 34, no. 3, p. 823-825
Publication date2002
Keywords
- Antibodies, Monoclonal/therapeutic use
- Blood Glucose/metabolism
- C-Peptide/blood
- Case-Control Studies
- Diabetes Mellitus, Type 1/surgery
- Diabetic Nephropathies/surgery
- Follow-Up Studies
- Graft Survival/physiology
- Hemoglobin A, Glycosylated/metabolism
- Humans
- Immunosuppressive Agents/therapeutic use
- Islets of Langerhans Transplantation/immunology/physiology
- Kidney Failure, Chronic/surgery
- Kidney Transplantation/immunology/physiology
- Recombinant Fusion Proteins
- Reoperation
- Retrospective Studies
- Time Factors
- Transplantation, Homologous
Citation (ISO format)
OBERHOLZER, José et al. Human islet allotransplantation with Basiliximab in type I diabetic patients with end-stage renal failure. In: Transplantation proceedings, 2002, vol. 34, n° 3, p. 823–825. doi: 10.1016/S0041-1345(01)02924-4
Main files (1)
Article (Published version)
Identifiers
- PID : unige:46458
- DOI : 10.1016/S0041-1345(01)02924-4
- PMID : 12034197
Journal ISSN0041-1345
